◆ 会议时间:2025年6月11-14日
◆ 会议地点:西班牙 巴塞罗那
◆ 会议简介:
2025年欧洲风湿病学大会(EULAR年会)将于2025年6月11-14日在西班牙巴塞罗那举行,会议由欧洲抗风湿病联盟(EULAR)主办。一年一度的EULAR大会是世界风湿病学日历中的重大事件,大会将汇集来自欧洲和世界各地的医师、科学家,各年龄段的患者及其家属,卫生保健专业人士和制药行业代表;一系列多样化的EULAR活动将展示传播风湿病学领域的最新研究进展,所有活动都致力于改善风湿性骨骼肌肉疾病或受其影响的人们的健康状况。EULAR大会将再次讨论广泛的议题,包括人口、卫生服务、临床、转化和基础科学等方面的创新,致力于欧洲关节炎和风湿病患者(PARE)和风湿病卫生专业人员(HPR)的会议将成为一个突出特色!并将再次提供高质量的卫生保健行业会议,提供深入和有重点的见解。2023EULAR与会人数:12,394人。
欧洲风湿病学大会(EULAR大会)起源于2000年,现已成为欧洲交流科学和临床信息的重要平台,是全球范围内的医生、科学家、关节炎/风湿病患者、卫生专业人员和医药行业代表之间互相交流的知名论坛,EULAR大会每年6月在欧洲的一个主要城市举行,每年都有10000余名来自世界各地的代表参会,EULAR大会的科学计划涵盖了临床创新、临床、转化和基础科学宣等广泛的议题,是执业医师获取新的临床研究信息的最具创新性的平台。
欧洲抗风湿病联盟(EULAR)成立于1947年,是代表所有欧洲国家的关节炎/风湿病患者、风湿病卫生专业人员(HPR)和风湿病科学协会的非营利性科学教育协会,致力于促进、推动和支持风湿与肌肉骨骼疾病(RMDs)的研究、预防、治疗和康复。EULAR现拥有45个科学学会会员,36个PARE组织和25个卫生专业人员协会以及23个企业成员。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。
EULAR 2025 - EULAR European Congress of Rheumatology
Date: 11-14 June, 2025
Venue: Fira Gran Via, Barcelona, Spain
Organized by: European Alliance of Associations for Rheumatology(EULAR)
以下为上届会议信息:
EULAR 2024 - EULAR European Congress of Rheumatology
Date: 12-15 June, 2024
Venue: Messe Wien Congress Center, Vienna, Austria
Organized by: European Alliance of Associations for Rheumatology(EULAR)
The aim of the European Congress of Rheumatology is to provide a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with rheumatic diseases.
Abstract submission-摘要提交
Regular Abstract submission opens on 1 October 2023 until 15 January 2024, 23:59 CET.
Clinical case report submission
opens on 1 October 2023 until 15 January 2024.
点此提交摘要>>>Submit Abstract>>>
点此查看更多摘要提交相关信息>>>
Dear Friends,
As the newly elected President of the European Alliance of Associations for Rheumatology (EULAR), I am honoured to address you all and extend my warmest greetings. Since its founding in 1947, EULAR has been a shining example of excellence in the field of Rheumatology. It has achieved a respected and esteemed reputation of significant importance throughout Europe.
At the heart of EULAR's remarkable endeavours, the EULAR European Congress of Rheumatology stands as our flagship event, delivering an unparalleled experience year after year. Our Congress brings together a vast network of patients, health professionals, rheumatologists and industry partners dedicated to highlighting the latest scientific breakthroughs in clinical, translational, and basic research. It serves as a platform for discussing new developments and management of rheumatic and musculoskeletal diseases (RMDs). Furthermore, the Congress focuses on bridging the gap between diagnosis and patient care and explores practical aspects of the rheumatology field through specialised workshops, presentations, and discussions.
In 2023, the EULAR Congress in Milan was a tremendous success with both onsite and online components, with extended access to the complete Scientific Programme until 31 December 2023. This innovative Congress had over 12,000 attendees, demonstrating our commitment to providing a high-quality experience.
The EULAR 2024 Congress is taking place in the beautiful city of Vienna, Austria, where we will foster knowledge sharing, innovation, and striving for excellence through collaboration. Vienna, with its rich history, cultural heritage, and warm hospitality, is a perfect location for our Congress.
EULAR 2024 will be a forum for exchanging groundbreaking research projects, best practices, and the latest advancements in rheumatology. Our esteemed speakers, and renowned experts in the field, will deliver insightful scientific sessions, abstract presentations and engaging, stimulating discussions. EULAR 2024 Scientific Program will be thoughtfully designed to address the pressing challenges and emerging possibilities that lie ahead. It will allow attendees to enhance their knowledge, exchange ideas, and forge meaningful connections with like-minded people from around the world.
I would like to thank all EULAR Community members and volunteers, the EULAR 2024 Congress Committee, and the EULAR Office for their dedication and hard work. I also want to give heartfelt gratitude to all delegates who will attend our excellent Congress in 2024.
On behalf of EULAR, I invite you to join us at the EULAR 2024 Congress in Vienna, 12 - 15 June 2024. Together, let us take advantage of this unique opportunity to improve management of RMDs, foster innovation, and shape the future of rheumatology.
With warmest regards,
Daniel Aletaha
EULAR President
注册费:
EULAR 2024 Registration Categories and Fees
Categories |
Fee as of
1 November 2023 (EUR)
fees are all taxes inclusive |
Fee as of
1 April 2024 (EUR)
fees are all taxes inclusive |
Delegates* ("ordinary" and "other") |
879 |
925 |
Trainees** ("ordinary" and "other") |
271 |
285 |
HPR Delegates |
181 |
190 |
Students***
(28 years old or below) |
- |
- |
PARE Delegates |
181 |
190 |
Patients & Family |
24 |
25 |
Company Delegates
("pharma" and "non-pharma") |
879 |
925 |
Exhibitors
(access to exhibition and company's own sessions only) |
200 |
200 |
* A proof of status (prescribing rights or non prescribing rights) will be required upon registration.
** A proof of status will be required upon registration.
*** A proof of age and student card/status will be required upon registration.
Access Rights
For all participants
- Access to the scientific sessions onsite and on demand content as of 12 June 2024 until 31 December 2024
- Access to all abstract sessions onsite and on demand content as of 12 June 2024 until 31 December 2024
Additionally for Ordinary Delegates and Ordinary Trainees
- Access to all satellite symposia, consult the expert events and industry exhibition onsite and on demand as of 12 June 2024 until 31 December 2024
Additionally for Company Representative "pharma"
- Access to all satellite symposia, consult the expert events and industry exhibition onsite and on demand as of 12 June 2024 until 31 December 2024
◆ 参会对象:医师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|